A5085059224- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Neuroendocrine Tumor Research Advances
- Lung Cancer Treatments and Mutations
- Metastasis and carcinoma case studies
Chinese PLA General Hospital
2022-2023
Adjuvant therapy for stage IB non-small cell lung cancer remains debatable. In this real-world study, we evaluate the efficacy and safety of adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) resected adenocarcinoma.This study recruited 249 patients diagnosed with disease after surgical resection between January 2013 September 2021. Sixty-six (26.5%) received targeted (TKIs group), 183 (73.5%) were enrolled in clinical observation (CO) group. Propensity scores...
In traditional opinion, solid pulmonary nodule suspected lung cancer should be confirmed by pathology before the operation to exclude small cell (SCLC), considering SCLC tends aggressive and surgical effect in management of remains controversial. The aim this study was evaluate survival result risk factors postoperative unsuspected SCLC.A total 120 patients with who were referred Chinese PLA General Hospital between 2000 2021 retrospectively analyzed (surgery group). Additionally,...
Objective: To investigate the survival and influencing factors of unexpected small cell lung cancer following surgery. Methods: We respectively reviewed clinical characters 104 patients who underwent surgical treatment be proved as by pathology between January 2000 to October 2020 in Chinese PLA General Hospital. Overall (OS) was evaluated using Kaplan-Meier Cox proportional hazards analysis. Results: Of patients, 27 cases showed central lesions, other 77 peripheral nodules. The margin...